glp 1 breast pain GLP-1 Agonists Poised to Impact Breast Cancer Care Case-Based Review of Breast Imaging

GLP-1 receptor agonists have now received FDA approvals for cardiovascular risk reduction, obstructive sleep apnea, and chronic kidney disease, in addition to their original diabetes and obesity indications

It is a recognized risk factor for conversion from minimally invasive to open surgery [57], which increases wound complications and may delay adjuvant therapy

Kuhre RE, Deacon CF, Holst JJ, Petersen N

Used together, the theory is that one addresses the immediate injury environment while the other supports the wider recovery process relevant for post-surgical recovery, athletic injury rehabilitation, chronic pain conditions, and general joint health and mobility

Join us and make this journey the one that sticks

Dermatology 15, 514519